title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"uniQure  ( QURE )  Up on Restructuring Plans, Workforce Reduction",20231006T153100,https://www.zacks.com/stock/news/2161746/uniqure-qure-up-on-restructuring-plans-workforce-reduction,DVAX,0.153961,Neutral,0.079756
"Uniqure Stock Sees Healthy Price Gain, Ranks Among Top 8%",20220711T223000,https://www.investors.com/news/technology/stock-upgrades-uniqure-n-v-shows-rising-relative-strength-3/,DVAX,0.172097,Neutral,0.080245
Assertio  ( ASRT )  Shares Fall as Dan Peisert Steps Down as CEO,20240104T144600,https://www.zacks.com/stock/news/2205675/assertio-asrt-shares-fall-as-dan-peisert-steps-down-as-ceo,DVAX,0.442339,Somewhat-Bullish,0.242451
Is Aquestive Therapeutics  ( AQST )  Stock Outpacing Its Medical Peers This Year?,20231213T144009,https://www.zacks.com/stock/news/2197351/is-aquestive-therapeutics-aqst-stock-outpacing-its-medical-peers-this-year,DVAX,0.495015,Somewhat-Bullish,0.289771
Aquestive  ( AQST )  Up on Reaffirming Anaphylm Development Pathway,20230921T162400,https://www.zacks.com/stock/news/2153848/aquestive-aqst-up-on-reaffirming-anaphylm-development-pathway,DVAX,0.152499,Neutral,0.059727
"Aquestive's  ( AQST )  Libervant Accepted for FDA Review, Stock Up",20230912T122600,https://www.zacks.com/stock/news/2147669/aquestives-aqst-libervant-accepted-for-fda-review-stock-up,DVAX,0.210579,Neutral,0.078483
110 Biggest Movers From Friday,20220516T092329,https://www.benzinga.com/news/22/05/27213491/110-biggest-movers-from-friday,DVAX,0.059552,Neutral,0.014037
110 Biggest Movers From Friday,20220516T092329,https://markets.businessinsider.com/news/stocks/110-biggest-movers-from-friday-1031463674,DVAX,0.036437,Neutral,0.012292
56 Stocks Moving In Friday's Mid-Day Session,20220513T161103,https://www.benzinga.com/news/22/05/27195036/56-stocks-moving-in-fridays-mid-day-session,DVAX,0.116086,Neutral,0.009054
